Jennifer Woyach, MD
Jennifer Woyach, MD, is hematologist-oncologist at The Ohio State University Comprehensive Cancer Center who specializes in treating patients with blood cancers, particularly chronic lymphocytic leukemia and B-cell lymphomas. She also serves as a professor in the Division of Hematology at The Ohio State University.
Articles
Woyach Discusses Updated BRUIN Data of Pirtobrutinib in CLL/SLL
December 20th 2023Jennifer A. Woyach, MD, discusses background and updated findings from the phase 1/2 BRUIN study of pirtobrutinib for the treatment of heavily pretreated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma after prior treatment with a covalent Bruton tyrosine kinase inhibitor.
Progression on Ibrutinib With the Acquisition of Resistance Mutations
July 26th 2014Jennifer Woyach, MD, assistant professor of Internal Medicine, Division of Hematology, The Ohio State University Comprehensive Cancer Center, discusses the association of disease progression on ibrutinib therapy with the acquisition of resistance mutations as seen at The Ohio State University Comprehensive Cancer Center.
Efficacy Findings from the RESONATE Trial
June 5th 2014Jennifer Woyach, MD, assistant professor of Internal Medicine, Division of Hematology, The Ohio State University Comprehensive Cancer Center, discusses the efficacy findings from the RESONATE trial, a phase III trial that compared ibrutinib versus ofatumumab in relapsed or refractory (R/R) chronic lymphocytic leukemia/small lymphocytic lymphoma.
